Imran Khan’s Post

What happens when a healthcare tech company needs to navigate multiple offers and a complex merger? MedQIA, LLC approached GHJ for strategic guidance amid an evolving industry landscape. Our Growth Planning and Strategic Advisory Practice evaluated their options, advised on investment banking selection and supported them through the merger process with WorldCare Clinical. The outcome? The creation of Voiant, an industry-leading AI-based clinical trial imaging platform. Learn how GHJ’s strategic approach can help achieve successful outcomes for your business. https://bit.ly/4dq5T2G #YourHomeTeamAdvantage

In terms of value, private equity deal activity in the UK saw a significant surge, increasing by 3254% in Q4 2023 compared to the previous quarter's total of $32.8 million, and marking an 8792% rise compared to Q4 2022. Despite this, related deal volume remained stable in Q4 2023 compared to the previous quarter, but was 33% lower than in Q4 2022. Within the British medical devices industry, GlobalData's Deals Database reported 2 private equity deals announced in Q4 2023, totaling $1.1 billion in value. The largest disclosed deal in the industry was the $1.1 billion institutional buy-out (IBO) of Alliance Medical Group by iCON Infrastructure Partners VI. For a comprehensive examination of disruptive themes and private equity deal activity, please refer to GlobalData's Medical Devices Industry Mergers and Acquisitions Deals by Top Themes report. https://lnkd.in/eG3M-TfZ. #GlobalData #Deals #UK #Themes #M&A #MedicalDevice

MedTech M&A Heating Up in 2024: Who's Next? Analysts predicted a surge, and we're starting to see it. Boston Scientific's Axonics, Inc. deal leads the pack, but Johnson & Johnson and Baxter International Inc. are also making moves this year. My Questions: Will the FTC play spoiler, or is the regulatory climate shifting for big medtech mergers? With these deals, does staying competitive mean going BIG or finding your niche? What under-the-radar companies are ripe for acquisition? Your Take? Share below in the comments! #MedTech #Acquisitions #HealthcareInnovation #MergersandAcquisitions #Baxter #Medtronic #Johnsonandjohnson

IMAP Medtech Sector Update - July 2024 "Innovation and growth are driving strategic buyers in MedTech. Companies are returning to the M&A market with a renewed focus on acquisitions. Mid-market activity will continue to dominate as large companies leverage cash reserves for tuck-in and innovative technology acquisitions. On the PE-backed side of the M&A market, low-risk medical devices and consumables are gaining prominence. SMEs are well-positioned to capitalise on this trend, offering investors attractive opportunities," shares Javeed Siddiqui, from IMAP UK. Link to full report, including global IMAP partner insights, in the comments below.

Organizations always tend to look for ways to acquire patents or technologies, license them, or even sell the ones they own. Interestingly, Relecura has the perfect tool that does all of the above and more. To know more about what we’re referring to, check out this cool video! #organizations #acquisition #patents #technologies #licenseorsell #dataassetmanagement #taxonomybuilder #relecura

How can strategic guidance and unconflicted advice transform a business? MedQIA, LLC turned to GHJ amidst two prospective offers in the evolving healthcare tech industry. Our Growth Planning and Strategic Advisory Practice evaluated the offers, advised on investment banking selection and supported MedQIA throughout a complex merger process. The result? A successful merger with WorldCare Clinical to create Voiant, a leading AI-based clinical trial imaging platform. Discover how GHJ’s expertise can position your business for long-term success. https://bit.ly/4dq5T2G #YourHomeTeamAdvantage

𝐆𝐨𝐨𝐝𝐰𝐢𝐧 𝐀𝐝𝐯𝐢𝐬𝐞𝐬 𝐆𝐢𝐥𝐝𝐞 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐨𝐧 𝐀𝐜𝐪𝐮𝐢𝐬𝐢𝐭𝐢𝐨𝐧 𝐅𝐢𝐧𝐚𝐧𝐜𝐢𝐧𝐠 𝐟𝐨𝐫 𝐊𝐨𝐬𝐜𝐡𝐞𝐫 & 𝐖ü𝐫𝐭𝐳 This move marks a significant step for Gilde Healthcare as it aspires to create a group of leading contract manufacturers of surgical instruments. Read More: https://bityl.co/MbZF #Goodwin #gildehealthcare #healthcare #acquisitions #news #newsupdate #manufacturing #surgicalinstruments #latestnews

TrueIP has developed a cost-effective Commercialisation Search Report, designed to pinpoint global distribution or acquisition partners for Australian businesses. For instance, an Australian MedTech startup sought TrueIP's assistance in identifying USA and European partners with a specific gap in their market service catering to General Practitioners (Medical Practices/Centers). This approach saves considerable resources and time compared to direct outreach to decision makers. Additionally, the report identifies potential acquisition opportunities for businesses lacking in their service offering, which this device could compliment their offering. Contact TrueIP on +61 (0) 431 162 212 #patent search #intellectual property #EMDG #RDTI #commercialisation #go-to-market #cusatomer acquisition

Another week, another round of hot deals and exciting news in the world of M&A! We've handpicked a selection of last week's closed deals for you. For more details and to discover all the deals in the sector that interests you (and much more!): https://lnkd.in/enTvMFuU News Week 13-24 🚀 Add-on MoxeXM (Hesse / DEU), a specialist in software and platform development for customer experience management (CXM), acquires Feeddex and 5-sterrenspecialist. This double acquisition, supported by Pride Capital Partners, enables MoxeXM to expand its CXM offering in Europe. 🚀 Acquisition Accession Capital Partners invests in WAWRZASZEK ISS (WISS) (Silesia / POL), a manufacturer of specialized fire and emergency vehicles. ACP will support the company's growth in partnership with founder Piotr Wawrzaszek and his family. 🚀 Acquisition Siparex acquires a majority stake in Capron Podologie (c. €23M in revenue in 2023, Bourgogne-Franche-Comté / FRA), a manufacturer of equipment for podiatrists and chiropodists. This transaction, led by the Siparex Midcap 4 fund, will enable the company to accelerate its international expansion. 🚀 Exit Ingersoll Rand ($5.5 billion of revenue in 2022, Leinster / IRL), an industrial company specializing in the design and manufacture of compressors, blowers, pumps, vacuum products, fluid transfer products, and material handling equipment, has acquired ILC Dover (Delaware / USA), a company specializing in the design and production of flexible containment solutions for the biopharmaceutical, pharmaceutical, medical device, and aerospace markets. With this acquisition, Ingersoll will expand its customer base and develop in high-growth end markets such as life sciences. Notably, ILC Dover's investors included Linden Capital Partners and New Mountain Capital, who thus contributed to its success. Don't miss the latest trends and news from the world of investment funds by following our page. #InvestmentFunds #PrivateEquity #MergerandAcquisition

🚀 We are thrilled to announce that we have successfully obtained a Canadian patent! This significant milestone not only enhances our intellectual property portfolio but also positions us for increased valuation at potential exit opportunities. 💡 To our current and future investors - this is an opportune moment to be part of a journey that promises substantial returns. Stay tuned for more updates as we pave the way forward in our industry! #ComeBackMobility #Medicaldevice #InvestmentOpportunity #TechStars #PatentSuccess